title: Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
abstract: We conducted a nested case-control study within a cohort of elderly Americans to examine the role of the insulin-like growth factor (IGF) signaling pathway in prostate cancer etiology. The distribution of genotypes of IGF-I (CA)n, IGF binding protein-3 (IGFBP-3) A-202C, and of the 2-bp deletion and (AGG)n polymorphisms in IGF-I receptor (IGF-IR) was compared between men with prostate cancer (n = 213) and equal number of controls matched on year of blood draw, survival until the date of diagnosis, race, and age. Among controls, the number of CA repeats in IGF-I was not correlated to any appreciable degree with plasma IGF-I concentration, whereas the IGFBP-3 CC genotype was associated with a relatively low level of plasma IGFBP-3. There was no association between prostate cancer risk and the number of CA repeats in IGF-I, IGFBP-3 genotype, or the presence of the 2-bp deletion in IGF-IR. There was a small increased risk among men who did not carry two copies of the (AGG)7 allele of IGF-IR. These results add to the evidence that the number of IGF-I CA repeats is not associated with prostate cancer risk. Our observation that men who do not carry two copies of the IGF-IR (AGG)7 allele are at increased risk of prostate cancer merits further investigation.
authors.affiliation: Program in Epidemiology, Fred Hutchinson Cancer Research Center, WA, USA.
authors.forename: Chu
authors.initials: C
authors.lastname: Chen
authors.forename: Robert
authors.initials: R
authors.lastname: Freeman
authors.forename: Lynda F
authors.initials: LF
authors.lastname: Voigt
authors.forename: Annette
authors.initials: A
authors.lastname: Fitzpatrick
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Plymate
authors.forename: Noel S
authors.initials: NS
authors.lastname: Weiss
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D018900:Dinucleotide Repeats; D005838:Genotype; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood / Q000235:genetics*; D007334:Insulin-Like Growth Factor I / Q000235:genetics* / Q000378:metabolism; D008297:Male; D011110:Polymorphism, Genetic; D011471:Prostatic Neoplasms / Q000097:blood / Q000235:genetics*; D017526:Receptor, IGF Type 1 / Q000097:blood / Q000235:genetics*; D012307:Risk Factors
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1